14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ALXN
Delisted

Alexion Pharmaceuticals Stock Price (Quote)

$182.50
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $182.50 $182.50 Friday, 27th May 2022 ALXN stock ended at $182.50. During the day the stock fluctuated 0% from a day low at $182.50 to a day high of $182.50.
90 days $182.50 $182.50
52 weeks $174.72 $187.45

Historical Alexion Pharmaceuticals prices

Date Open High Low Close Volume
Oct 29, 2019 $106.57 $108.06 $106.57 $107.49 1 534 056
Oct 28, 2019 $105.00 $106.86 $104.20 $106.56 1 466 361
Oct 25, 2019 $105.09 $105.68 $103.32 $105.18 1 547 768
Oct 24, 2019 $107.86 $108.00 $104.31 $106.08 1 930 850
Oct 23, 2019 $101.00 $107.04 $100.95 $106.63 4 396 521
Oct 22, 2019 $101.99 $103.73 $98.74 $99.28 2 461 060
Oct 21, 2019 $100.00 $101.36 $98.53 $100.73 1 770 533
Oct 18, 2019 $100.29 $100.45 $97.59 $98.41 1 598 694
Oct 17, 2019 $101.20 $101.79 $99.47 $99.99 1 439 535
Oct 16, 2019 $102.80 $104.90 $99.41 $99.51 2 699 812
Oct 15, 2019 $101.60 $105.13 $101.50 $104.81 1 767 409
Oct 14, 2019 $99.50 $103.14 $98.73 $101.34 2 041 666
Oct 11, 2019 $99.13 $101.16 $98.92 $99.25 1 181 591
Oct 10, 2019 $95.30 $98.46 $94.66 $98.35 1 373 724
Oct 09, 2019 $96.46 $96.99 $94.59 $94.84 1 741 075
Oct 08, 2019 $97.16 $97.18 $95.50 $95.80 1 487 281
Oct 07, 2019 $98.17 $98.87 $96.62 $97.35 1 274 581
Oct 04, 2019 $99.26 $99.85 $96.68 $98.03 1 510 400
Oct 03, 2019 $97.01 $99.40 $96.63 $99.17 1 547 676
Oct 02, 2019 $97.26 $98.52 $95.02 $97.48 1 432 702
Oct 01, 2019 $98.58 $98.99 $96.41 $97.79 1 854 847
Sep 30, 2019 $98.27 $99.07 $97.51 $97.94 1 425 051
Sep 27, 2019 $98.76 $100.77 $97.44 $97.77 1 521 414
Sep 26, 2019 $101.60 $101.60 $96.55 $98.70 1 968 144
Sep 25, 2019 $100.26 $101.95 $99.00 $100.40 1 639 879
Click to get the best stock tips daily for free!

About Alexion Pharmaceuticals

Alexion Pharmaceuticals Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood disorder; and atypical hemolytic uremic syndrome (aHUS), a genetic disease. It provides Strensiq (asfotase alfa), a targeted enzyme replacement therapy for patients with hypophosp... ALXN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT